X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES VENUS REMEDIES JUBILANT LIFE SCIENCES/
VENUS REMEDIES
 
P/E (TTM) x 27.4 -711.4 - View Chart
P/BV x 5.6 0.2 2,707.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   VENUS REMEDIES
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
VENUS REMEDIES
Mar-16
JUBILANT LIFE SCIENCES/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs187218 85.7%   
Low Rs6582 79.3%   
Sales per share (Unadj.) Rs364.3365.6 99.7%  
Earnings per share (Unadj.) Rs6.81.5 460.7%  
Cash flow per share (Unadj.) Rs24.537.9 64.6%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.9382.5 43.1%  
Shares outstanding (eoy) m159.2811.44 1,392.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 84.2%   
Avg P/E ratio x18.4101.0 18.2%  
P/CF ratio (eoy) x5.14.0 129.9%  
Price / Book Value ratio x0.80.4 194.7%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0611,717 1,168.7%   
No. of employees `0006.21.0 606.4%   
Total wages/salary Rs m11,052324 3,406.8%   
Avg. sales/employee Rs Th9,383.04,100.7 228.8%   
Avg. wages/employee Rs Th1,786.9318.0 561.8%   
Avg. net profit/employee Rs Th176.316.7 1,057.8%   
INCOME DATA
Net Sales Rs m58,0344,183 1,387.5%  
Other income Rs m19120 948.3%   
Total revenues Rs m58,2244,203 1,385.4%   
Gross profit Rs m5,786812 712.9%  
Depreciation Rs m2,812417 674.6%   
Interest Rs m3,237380 852.3%   
Profit before tax Rs m-7235 -205.4%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m69618 3,847.5%   
Profit after tax Rs m1,09017 6,414.1%  
Gross profit margin %10.019.4 51.4%  
Effective tax rate %-965.951.6 -1,873.1%   
Net profit margin %1.90.4 462.3%  
BALANCE SHEET DATA
Current assets Rs m29,2802,771 1,056.8%   
Current liabilities Rs m38,9121,931 2,014.7%   
Net working cap to sales %-16.620.1 -82.7%  
Current ratio x0.81.4 52.5%  
Inventory Days Days84125 67.5%  
Debtors Days Days5154 94.3%  
Net fixed assets Rs m55,7125,328 1,045.5%   
Share capital Rs m155114 135.1%   
"Free" reserves Rs m20,9684,177 502.0%   
Net worth Rs m26,2654,376 600.2%   
Long term debt Rs m17,1691,911 898.7%   
Total assets Rs m88,6068,428 1,051.3%  
Interest coverage x1.01.1 89.5%   
Debt to equity ratio x0.70.4 149.7%  
Sales to assets ratio x0.70.5 132.0%   
Return on assets %4.94.7 103.7%  
Return on equity %4.20.4 1,068.7%  
Return on capital %11.66.6 175.3%  
Exports to sales %37.80-   
Imports to sales %16.520.5 80.3%   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567858 1,114.6%   
Fx inflow Rs m22,0040-   
Fx outflow Rs m11,749858 1,368.9%   
Net fx Rs m10,255-858 -1,194.8%   
CASH FLOW
From Operations Rs m8,026469 1,712.1%  
From Investments Rs m-1,74429 -5,973.3%  
From Financial Activity Rs m-4,447-464 959.5%  
Net Cashflow Rs m1,83435 5,317.2%  

Share Holding

Indian Promoters % 45.6 32.9 138.8%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 0.2 4,833.3%  
FIIs % 21.2 0.6 3,655.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 66.4 31.8%  
Shareholders   23,815 20,121 118.4%  
Pledged promoter(s) holding % 15.9 36.4 43.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   UNICHEM LAB  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SHASUN PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 16, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - TORRENT PHARMA COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS